Autotolerant ceruloplasmin based biocathodes for implanted biological power sources.


Journal

Bioelectrochemistry (Amsterdam, Netherlands)
ISSN: 1878-562X
Titre abrégé: Bioelectrochemistry
Pays: Netherlands
ID NLM: 100953583

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 27 08 2020
revised: 19 02 2021
accepted: 20 02 2021
pubmed: 22 3 2021
medline: 16 9 2021
entrez: 21 3 2021
Statut: ppublish

Résumé

High-performance autotolerant bioelectrodes should be ideally suited to design implantable bioelectronic devices. Because of its high redox potential and ability to reduce oxygen directly to water, human ceruloplasmin, HCp, the only blue multicopper oxidase present in human plasma, appears to be the ultimate biocatalyst for oxygen biosensors and also biocathodes in biological power sources. In comparison to fungal and plant blue multicopper oxidases, e.g. Myrothecium verrucaria bilirubin oxidase and Rhus vernicifera laccase, respectively, the inflammatory response to HCp in human blood is significantly reduced. Partial purification of HCp allowed to preserve the native conformation of the enzyme and its biocatalytic activity. Therefore, electrochemical studies were carried out with the partially purified enzyme immobilised on nanostructured graphite electrodes at physiological pH and temperature. Amperometric investigations revealed low reductive current densities, i.e. about 1.65 µA cm

Identifiants

pubmed: 33744681
pii: S1567-5394(21)00057-8
doi: 10.1016/j.bioelechem.2021.107794
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Enzymes, Immobilized 0
Graphite 7782-42-5
Ceruloplasmin EC 1.16.3.1
Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107794

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The author declare that there is no conflict of interest.

Auteurs

Olga Aleksejeva (O)

Department of Biomedical Science, Malmö University, 205 06 Malmö, Sweden. Electronic address: olga.aleksejeva@mau.se.

Alexey V Sokolov (AV)

Institute of Experimental Medicine, 197376 Saint-Petersburg, Russia Saint-Petersburg State University, 199034 Saint-Petersburg, Russia.

Inmaculada Marquez (I)

Department of Physical Chemistry, University of Seville, 41012 Seville, Spain.

Anna Gustafsson (A)

Department of Biomedical Science, Malmö University, 205 06 Malmö, Sweden.

Sergey Bushnev (S)

Federal Research Centre "Fundamentals of Biotechnology," Russian Academy of Sciences, Moscow 119071, Russia.

Håkan Eriksson (H)

Department of Biomedical Science, Malmö University, 205 06 Malmö, Sweden.

Lennart Ljunggren (L)

Department of Biomedical Science, Malmö University, 205 06 Malmö, Sweden.

Sergey Shleev (S)

Department of Biomedical Science, Malmö University, 205 06 Malmö, Sweden; Federal Research Centre "Fundamentals of Biotechnology," Russian Academy of Sciences, Moscow 119071, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH